Nuwellis Inc

Insider option exercises at Nuwellis signal confidence in its new patented dual‑lumen catheter and SmartFlow system, hinting at upside despite a modest market cap.

Insider option buying at Nuwellis hints at a potential upside from its new dual‑lumen catheter patent – but investors should watch regulatory milestones and market uptake for real value.